BRIEF-Roche CEO says diabetes mkt remains difficult, bullish on U.S.

* 2017 profit growth to only match sales growth due to investments in new products [Source]

Publication Date: Wednesday, 1 February 2017 at 09:41:18

Origin: reuters.com

Category: rbssHealthcareNews

Topics: growth, products, to investments, sales, match, profit, bullish, difficult, remains, diabetes, BRIEF-Roche

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/URzGlqNIdE0/idUSFWN1FM08N

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22